Multiple Sclerosis Clinical Trial
Official title:
Comparison of the Effects of Internet-Based and Supervised Exercise Programs in People With Multiple Sclerosis
The main aim of this study is resarch and compare the effects of supervised exercise programs and internet-based exercise programs, which have started to benefit from their effects in recent years, known for not requiring conditions such as transportation distance, cost and time, on motor disorders and quality of life in people with multiple sclerosis (MS). This study conducting for develop a new perspective on conventional physiotherapy and rehabilitation practices. Our study will be performed in people with MS with a high EDSS score, is seen as an important contribution for the literature.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | October 29, 2024 |
Est. primary completion date | May 29, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Diagnosed with MS by a neurologist - Being between ages of 18-65 - Not having had an attack in the last 3 months - The score of Expanded Disability Status Scale (EDSS) is 5.5- 7.5 - Not participating in a another physiotherapy and rehabilitation program - Having internet access Exclusion Criteria: - Pregnancy - Severe cognitive impairment that effects participating to rehabilitation - The cardiopulmonary disease that will prevent aerobic exercise - Having a major hearing and/or vision problem - Having a major speech disorder |
Country | Name | City | State |
---|---|---|---|
Turkey | Istanbul University- Cerrahpasa | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Istanbul University - Cerrahpasa (IUC) |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 2 Minutes Walk Test (2MWT) (The change between the initial value and the value after 2 months will be evaluated). | This test is performed for the assessment of walking endurance. The patient is informed about the test before starting the test. The distance that a person walks along a 25-meter corridor in 2 minutes is calculated in meters. During the test, patients who have tiredness and shortness of breath can have a rest. | Baseline and end of weeks 8. | |
Secondary | Fatigue Severity Scale (FSS) (The change between the initial value and the value after 2 months will be evaluated). | It is a scale used for the evaluation of fatigue in MS patients. It consists of a total of 9 questions. A minimum of 1 and a maximum of 7 points can be scored from each question. The minimum score that can be obtained from the test is 9 the maximum score is 63. High scores mean that fatigue has increased. Validity and reliability studies have been conducted in Turkish MS patients of the FSS. | Baseline and end of weeks 8. | |
Secondary | 12 Item MS Walking Scale (MSWS- 12) (The change between the initial value and the value after 2 months will be evaluated). | It is used for evaluating walking ability in MS patients. This scale evaluates the limitations faced by MS patients in walking in the last two weeks. Situations such as loss of balance during walking, running, going up and down stairs, standing and walking, slowing down of walking are questioned. It is a Likert-type scale consisting of 12 questions. Each question score to between 1 and 5 points. The high scores indicate that the ability to walk is affected or that there is difficulty in walking. | Baseline and end of weeks 8. | |
Secondary | Modified Falls Efficacy Scale (MFES) (The change between the initial value and the value after 2 months will be evaluated). | The MFES aims to assess the impact of a person's fear of falling on daily living activities. MFES is consist of 14 items (10 indoor and 4 outdoor activitiy) and every question can score to 0-10. Low scores indicates high fear of falling. | Baseline and end of weeks 8. | |
Secondary | Canadian Occupational Performance Measure (COPM) (The change between the initial value and the value after 2 months will be evaluated). | COPM evaluates the activities that a person has difficulty doing in daily life between 1-10 points as activity performance and satisfaction score. At least one, up to 5 activities can be written, resulting in a total performance and satisfaction score. These scores are divided by the number of activities written, resulting in an average performance and satisfaction score. A validity and reliability study of the scale was conducted in individuals with MS. | Baseline and end of weeks 8. | |
Secondary | Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) (The change between the initial value and the value after 2 months will be evaluated). | ): It is a scale that assess the quality of life in MS patients. MusiQoL has 9 subgroups and 31 questions. During the evaluation, patients are asked to take into account their condition for the last 4 weeks. The answers to each question and the points that can be obtained; It is never/ Never (0 points), Rarely/ A little (1 point), Sometimes/ A little (2 points), Often/ A lot (3 points), Always/ Too much (4 points). The lowest score that can be taken from the scale is 0, the highest score is 124, and a high score indicates a low quality of life. | Baseline and end of weeks 8. | |
Secondary | The Multiple Sclerosis Impact Scale (MSIS- 29) (The change between the initial value and the value after 2 months will be evaluated). | ): It is a scale consisting of a total of 29 items that evaluate the consequences of symptoms and limitations caused by MS. It is a Likert type scale consisting of 5 points that evaluates the severity of symptoms such as fatigue, tremor, muscle spasm, personal care activities, sleep problems, concentration disorders. 1= having no problems at all, 2= having very few problems, 3= having moderate problems, 4= having severe problems, 5= having very severe problems. A total of at least 29 and a maximum of 145 points. A high score indicates a high amount of yeti loss. | Baseline and end of weeks 8. | |
Secondary | Berg Balance Scale (BBS) (The change between the initial value and the value after 2 months will be evaluated). | BBS developed for the functional assessment of balance in adults. it consists of 14 divisions. Each section is scored 0 to 4 points. 0= cannot do the task, 4= does it independently. A minimum of 0 and a maximum of 56 points can be scored. Low scores indicate a balance disorder. 0-20 points indicate a balance disorder, 21-40 points indicate an acceptable balance, 41-56 points indicate the presence of a good balance. There is a validity and reliability study of the scale in MS patients. | Baseline and end of weeks 8. | |
Secondary | 5 Times Sit to Stand Test (5TSTS) (The change between the initial value and the value after 2 months will be evaluated). | The patient is asked to sit on a chair with his arms crossed in a way to hold the other shoulders. The patient is told to sit down and get up 5 times as fast as possible. The test is terminated as soon as the person's pelvic area comes into contact with the chair. Increased time indicates a disturbed balance. The test has validity in MS patients. | Baseline and end of weeks 8. | |
Secondary | Timed 25- Foot Walk (T25- FW) (The change between the initial value and the value after 2 months will be evaluated). | It is used for the evaluation of walking speed in MS patients. the patient is asked to walk the distance of 7.62 meters (25 steps) as fast as possible. The time is calculated in seconds. The timed 25-step walking test is known as a very suitable test for evaluating walking speed in MS patients. | Baseline and end of weeks 8. | |
Secondary | Timed Get up and Go Test (TUG) (The change between the initial value and the value after 2 months will be evaluated). | TUG used to measure the balance and functional capacities of MS patients. The patient is asked to sit on a chair and a distance of 3 meters is determined. It is requested that the patient be with a shoe that he always uses. The patient is asked to get up from the chair, walk this distance and sit in the chair again. At this time, the time is kept in seconds by the stopwatch. High test times means reduce balance and high risk of falling. Its use in individuals with MS has been shown to be reliable and valid. | Baseline and end of weeks 8. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|